Top Picks: Vaxcyte (PCVX) (Copy)
Occasionally, we delve deeper into some of our top ideas. Please see our presentation on Vaxcyte below
Previous
Previous
Portfolio Rationales: February 2026 (Copy)
Next
Next
Occasionally, we delve deeper into some of our top ideas. Please see our presentation on Vaxcyte below